Achieve Life Sciences(ACHV) - 2025 Q2 - Quarterly Results
"Submitting the NDA on schedule is an important milestone that reflects the hard work and dedication of our team and partners," said Dr. Cindy Jacobs, President and Chief Medical Officer of Achieve Life Sciences. "Cytisinicline is supported by a comprehensive clinical data package, and we're committed to working closely with the FDA to advance this important potential treatment option for adults seeking to overcome nicotine dependence." • Submitted a New Drug Application (NDA) to the U.S. Food and Drug Admi ...